Thomas J. Lynch Jr. - Oct 27, 2022 Form 3 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Oct 27, 2022
Transactions value $
$0
Form type
3
Date filed
10/31/2022, 04:01 PM
Next filing
Jun 22, 2023

No securities are beneficially owned.